39 min listen
How Biotechs Survive the Valley of Death (REDUX)
FromI AM BIO
ratings:
Length:
25 minutes
Released:
Jan 10, 2024
Format:
Podcast episode
Description
For biotech companies, the valley of death describes the difficult path from initial discovery to FDA approval and commercialization. It's a treacherous journey—one that even promising innovations often don't complete. Adequate funding, regulatory hurdles and the immense complexity of the biotech landscape are among the never-ending challenges faced by early stage biotechs. In this episode we talk with two biotech executives about what it’s like to struggle and survive in this rough-and-tumble industry. Follow us on LinkedIn, X, Facebook and Instagram. Visit us at https://www.bio.org/
Released:
Jan 10, 2024
Format:
Podcast episode
Titles in the series (100)
Destroying COVID's Genome: Alnylam Pharmaceuticals, which take its name from the center and brightest star in Orion’s Belt, is working on an RNAi therapy to destroy the genome of the novel coronavirus — and with it, its ability to replicate and kill. Hosted by Jim Greenwood. by I AM BIO